BMO Capital Maintains Outlook On ICON Public Limited Company (ICLR) After Management Call

Core Viewpoint - ICON Public Limited Company (NASDAQ:ICLR) is considered a cheap healthcare stock with potential for investment as it heads into 2026, maintaining a 'Market Perform' rating and a price target of $175 by BMO Capital [1][4]. Group 1: Company Performance and Outlook - The company is experiencing elevated cancellation rates, which are expected to persist in the upcoming quarters, although it is believed to have passed through its worst period [4]. - ICON is focusing on increasing investments in automation and agentic AI, which may enhance its operational efficiency [2]. - The company has a one-year median price target of $213.50, indicating an upside potential of nearly 15% from its current levels [5]. Group 2: Analyst Insights - BMO Capital initiated coverage on ICON on November 13, maintaining a 'Market Perform' rating and a price target of $175, reflecting a cautious but optimistic outlook [4]. - Analysts covering the stock generally have a 'Buy' or equivalent rating, suggesting a positive sentiment towards ICON's future performance [5].